BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31000486)

  • 1. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
    Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
    Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy: A multicenter study.
    Kang HW; Lee SK; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
    J Surg Oncol; 2016 Jul; 114(1):70-4. PubMed ID: 27074886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
    Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes.
    Ray S; Cheaib JG; Biles MJ; Pineault KG; Johnson MH; Ged YMA; Markowski MC; Singla N; Allaf ME; Pierorazio PM
    Urology; 2021 Aug; 154():201-207. PubMed ID: 33864855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.
    Wood EL; Adibi M; Qiao W; Brandt J; Zhang M; Tamboli P; Matin SF; Wood CG; Karam JA
    J Urol; 2018 Feb; 199(2):393-400. PubMed ID: 28941919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34.
    Kryvenko ON
    Urol Oncol; 2017 Jun; 35(6):449-450. PubMed ID: 28416109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors.
    Shah PH; Moreira DM; Okhunov Z; Patel VR; Chopra S; Razmaria AA; Alom M; George AK; Yaskiv O; Schwartz MJ; Desai M; Vira MA; Richstone L; Landman J; Shalhav AL; Gill I; Kavoussi LR
    J Urol; 2016 Aug; 196(2):327-34. PubMed ID: 26907508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
    Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
    BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma.
    Iimura Y; Kihara K; Saito K; Masuda H; Kobayashi T; Kawakami S
    Int J Urol; 2008 Jan; 15(1):44-7. PubMed ID: 18184170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
    Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
    Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.
    Tellini R; Antonelli A; Tardanico R; Fisogni S; Veccia A; Furlan MC; Carobbio F; Cozzoli A; Zanotelli T; Simeone C
    Clin Genitourin Cancer; 2019 Feb; 17(1):e26-e31. PubMed ID: 30266249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
    Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
    BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes.
    Romeo A; Garcia Marchiñena P; Jurado AM; Gueglio G
    Urol Oncol; 2020 Feb; 38(2):42.e7-42.e12. PubMed ID: 31711833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-parenchyma interface and long-term oncologic outcomes after robotic tumor enucleation for sporadic renal cell carcinoma.
    Minervini A; Campi R; Di Maida F; Mari A; Montagnani I; Tellini R; Tuccio A; Siena G; Vittori G; Lapini A; Raspollini MR; Carini M
    Urol Oncol; 2018 Dec; 36(12):527.e1-527.e11. PubMed ID: 30268711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter?
    Sutherland SE; Resnick MI; Maclennan GT; Goldman HB
    J Urol; 2002 Jan; 167(1):61-4. PubMed ID: 11743276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
    Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
    Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.